⌘K
EN
FR
EPCAT II STUDY (Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty) | Government contract · CanPursue
Contracts
EPCAT II STUDY (Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty)
Capital District Health Authority
Ford's Family Pharmacy
RFPCH2012-0805
Open official source
Watch
Total contract value
$13,153.85
Original award value
$13,153.85
Start
Sep 19, 2012
End
—
Timeline
Official
Awarded
Sep 19, 2012. Original award value: $13,153.85